Evidence map›Paper›PMID 37978423›Full record

ArticleBMC microbiology2023

Molecular characteristics of Neisseria meningitidis carriage strains in university students in Lithuania.

Inga Ivaškevičienė, Justina Silickaitė, Asta Mačionienė, Rimvydas Ivaškevičius, Aistė Bulavaitė, Vilmantas Gėgžna, Silvija Kiverytė, Božena Paškevič, Aurelija Žvirblienė, Milda Plečkaitytė

Abstract read
In one paragraph

Article in BMC microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Genetic characterization ofFrontiers in cellular and infection microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Inga IvaškevičienėClinic of Children's Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Justina SilickaitėInstitute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania.
Asta MačionienėCenter of Laboratory Medicine, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
Rimvydas IvaškevičiusClinic of Children's Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Aistė BulavaitėInstitute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania.
Vilmantas GėgžnaInstitute of Biosciences, Life Sciences Center, Vilnius University, Vilnius, Lithuania.
Silvija KiverytėCenter of Laboratory Medicine, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
Božena PaškevičClinic of Children's Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Aurelija ŽvirblienėInstitute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania.
Milda PlečkaitytėInstitute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania. milda.pleckaityte@bti.vu.lt.

Funding

A Randomized Trial of Fistula vs. Graft Arteriovenous Vascular Access in Older Adults with End-Stage Kidney Disease on Hemodialysis: The AV ACCESS TrialR01AG071803 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ALLON, MICHAEL, MUREA, MARIANA · 2021 to 2025
$5.6M
The European Regional Development Fund under a grant agreement with the Research Council of Lithuania No 01.2.2-LMT-K-718-03-0036
6 · The paper itself

Abstract

backgroundNeisseria meningitidis can be carried asymptomatically in the human oropharynx without causing symptoms. Meningococcal carriage is relevant to the epidemiology of invasive meningococcal disease (IMD). No carriage studies have been performed among the general population in Lithuania, whereas the incidence of IMD in Lithuania was among the highest in European countries from 2009 to 2019.

resultsWe analyzed a total of 401 oropharyngeal samples collected from university students from December 2021 to February 2023 for N. meningitidis carriage using direct swab PCR assays and culture. The overall carriage prevalence based on both or either swab PCR or culture was 4.99%. PCR-based assays were used to characterize 15 carriage isolates, including detection of genogroup, multilocus sequence typing profile, and typing of antigens PorA and FetA. The most common carriage isolates were capsule null locus (cnl), accounting for 46.7%, followed by genogroups B (26.7%) and Y (13.3%). We also performed a molecular characterization of invasive N. meningitidis isolates collected during the COVID-19 pandemic and post-pandemic period to understand better the meningococcal carriage in the context of prevailing invasive strains. Despite the substantial decrease in the incidence of IMD during the 2020-2022 period, clonal complex 32 (CC32) of serogroup B continued to be the most prevalent IMD-causing CC in Lithuania. However, CC32 was not detected among carriage isolates. The most common CCs were CC269, CC198, and CC1136. The antigen peptide variants found in most carried isolates were classified as 'insufficient data' according to the MenDeVAR Index to evaluate the potential coverage by the 4CMenB vaccine. Nearly half of the isolates were potentially covered by the Men-Fhbp vaccine. Resistance to ciprofloxacin was detected only for one cnl isolate. All isolates were susceptible to penicillin and ceftriaxone. Our analysis identified frequent partying (≥ 4 times/month) as a risk factor for meningococcal carriage, whereas smoking, living in a dormitory, and previous COVID-19 illness were not associated with the carriage.

conclusionsOur study revealed a low prevalence of meningococcal carriage among university students in Lithuania. The carriage isolates showed genetic diversity, although almost half of them were identified as having a null capsule locus.

Indexed as

Meningococcal InfectionsMeningococcal VaccinesNeisseria meningitidisAntigens, BacterialBacterial VaccinesFemaleHumansLithuaniaMalePandemicsSerogroupStudentsUniversitiesAntigens, BacterialBacterial VaccinesMeningococcal VaccinesInvasive meningococcal diseaseNeisseria meningitidisOropharyngeal carriageRisk factorsSerogroup BVaccine antigensVaccines

Identifiers

PMID37978423
PMCPMC10655475

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.